NMCSD NBHC Kearny Mesa COVID-19 Vaccine Trial [Image 5 of 6]

SAN DIEGO, CA, UNITED STATES

12.17.2020

Photo by Petty Officer 3rd Class Jacob L. Greenberg 

Naval Medical Center San Diego

201217-N-DA693-1050
SAN DIEGO (Dec. 17, 2020) Cherie Hohn, a phlebotomist assistant assigned to Naval Medical Center San Diego’s (NMCSD) Naval Branch Health Clinic (NBHC) Kearny Mesa, draws a patient’s blood for a preliminary, baseline antibody test for the Phase III trial of AstraZeneca’s coronavirus (COVID-19) vaccine candidate Dec. 17. The trial is part of Operation Warp Speed, a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. NMCSD’s mission is to prepare service members to deploy in support of operational forces, deliver high quality healthcare services and shape the future of military medicine through education, training and research. NMCSD employs more than 6,000 active duty military personnel, civilians, and contractors in Southern California to provide patients with world-class care anytime, anywhere. (U.S. Navy photo by Mass Communication Specialist 3rd Class Jake Greenberg)

• Date Taken: 12.17.2020
• Date Posted: 12.17.2020 17:18
• Photo ID: 6461276
• VIRIN: 201217-N-DA693-1050
• Resolution: 3976x2840
• Size: 778.11 KB
• Location: SAN DIEGO, CA, US